These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 8843916

  • 1. Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.
    Berger AS, Cheng CK, Pearson PA, Ashton P, Crooks PA, Cynkowski T, Cynkowska G, Jaffe GJ.
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2318-25. PubMed ID: 8843916
    [Abstract] [Full Text] [Related]

  • 2. Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis.
    Cheng CK, Berger AS, Pearson PA, Ashton P, Jaffe GJ.
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):442-53. PubMed ID: 7843913
    [Abstract] [Full Text] [Related]

  • 3. An intravitreal biodegradable sustained release naproxen and 5-fluorouracil system for the treatment of experimental post-traumatic proliferative vitreoretinopathy.
    Cardillo JA, Farah ME, Mitre J, Morales PH, Costa RA, Melo LA, Kuppermann B, Jorge R, Ashton P.
    Br J Ophthalmol; 2004 Sep; 88(9):1201-5. PubMed ID: 15317716
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Efficacy of 5-fluorouracil polyactic acid microsphere in prevention of proliferative vitreoretinopathy].
    Bi HS, Cui Y, Zhang JH, Wang XR, Xie XF.
    Zhonghua Yan Ke Za Zhi; 2006 Jan; 42(1):37-41. PubMed ID: 16638279
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The Effects of Ozurdex® (Dexamethasone Intravitreal Implant) on Experimental Proliferative Vitreoretinopathy.
    Kuo HK, Chen YH, Wu PC, Kuo YH.
    Ophthalmologica; 2015 Jan; 233(3-4):198-203. PubMed ID: 25721986
    [Abstract] [Full Text] [Related]

  • 8. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy.
    Mandava N, Blackburn P, Paul DB, Wilson MW, Read SB, Alspaugh E, Tritz R, Barber JR, Robbins JM, Kruse CA.
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3338-48. PubMed ID: 12356843
    [Abstract] [Full Text] [Related]

  • 9. [Triamcinolone acetonide in the prevention of experimental proliferative vitreoretinopathy].
    Liang HC, Hui YN, Cai YS.
    Zhonghua Yan Ke Za Zhi; 1994 Mar; 30(2):122-4. PubMed ID: 8001444
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Liposome-encapsulated 5-fluorouracil in the treatment of proliferative vitreoretinopathy.
    Joondeph BC, Peyman GA, Khoobehi B, Yue BY.
    Ophthalmic Surg; 1988 Apr; 19(4):252-6. PubMed ID: 3362494
    [Abstract] [Full Text] [Related]

  • 12. Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits.
    Yasukawa T, Kimura H, Tabata Y, Miyamoto H, Honda Y, Ogura Y.
    Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):672-8. PubMed ID: 12192462
    [Abstract] [Full Text] [Related]

  • 13. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
    Alikacem N, Yoshizawa T, Nelson KD, Wilson CA.
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Transferrin-ricin A chain toxin limits the development of experimental proliferative vitreoretinopathy.
    Handa JT, Keithahn MA, Jaffe GJ.
    Exp Eye Res; 1996 Jun; 62(6):689-96. PubMed ID: 8983950
    [Abstract] [Full Text] [Related]

  • 18. The effect of combined daunorubicin and triamcinolone acetonide treatment on a refined experimental model of proliferative vitreoretinopathy.
    Chen EP, Steinhorst UH, Samsa GP, Saloupis PT, Hatchell DL.
    Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2160-4. PubMed ID: 1607226
    [Abstract] [Full Text] [Related]

  • 19. Effect of intravitreal triamcinolone acetonide in the treatment of experimental Staphylococcus epidermidis endophthalmitis.
    Hosseini H, Mehryar M, Eghtedari M, Ahmadi F, Nowroozizadeh S.
    Curr Eye Res; 2009 Feb; 34(2):145-51. PubMed ID: 19219686
    [Abstract] [Full Text] [Related]

  • 20. Aclacinomycin A in the treatment of experimental proliferative vitreoretinopathy. Efficacy and toxicity in the rabbit eye.
    Steinhorst UH, Chen EP, Hatchell DL, Samsa GP, Saloupis PT, Westendorf J, Machemer R.
    Invest Ophthalmol Vis Sci; 1993 Apr; 34(5):1753-60. PubMed ID: 8473115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.